CG
ESPR

Cutler Group’s Esperion Therapeutics ESPR Stock Holding History

Cutler Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,600
Closed -$73K – 5511
2021
Q4 		$73K Buy
+14,600
New +$117K ﹤0.01% 2100
2020
Q2 		– Sell
-1,900
Closed -$46K – 4502
2020
Q1 		$46K Sell
1,900
-800
-30% -$42.2K ﹤0.01% 1765
2019
Q4 		$5K Buy
2,700
+1,600
+145% +$71.9K ﹤0.01% 3026
2019
Q3 		$26K Hold
1,100
– – ﹤0.01% 1984
2019
Q2 		$17K Hold
1,100
– – ﹤0.01% 2317
2019
Q1 		$24K Sell
1,100
-300
-21% -$13.5K ﹤0.01% 1905
2018
Q4 		$25K Sell
1,400
-11,200
-89% -$540K ﹤0.01% 1946
2018
Q3 		$126K Buy
12,600
+2,900
+30% +$133K 0.01% 1066
2018
Q2 		$42K Buy
9,700
+4,600
+90% +$232K ﹤0.01% 1717
2018
Q1 		$47K Sell
5,100
-6,200
-55% -$455K ﹤0.01% 1705
2017
Q4 		$18K Buy
11,300
+5,600
+98% +$302K ﹤0.01% 2640
2017
Q3 		$16K Sell
5,700
-55,000
-91% -$2.65M ﹤0.01% 3324
2017
Q2 		$57K Sell
60,700
-16,600
-21% -$610K ﹤0.01% 2359
2017
Q1 		$141K Buy
+77,300
New +$1.77M 0.01% 1452
2016
Q4 		– Sell
-2,700
Closed -$1K – 6708
2016
Q3 		$1K Buy
2,700
+2,200
+440% +$24.9K ﹤0.01% 6092
2016
Q2 		$1K Buy
500
+300
+150% +$4.97K ﹤0.01% 6037
2016
Q1 		$2K Sell
200
-2,900
-94% -$46.6K ﹤0.01% 5543
2015
Q4 		$52K Buy
+3,100
New +$78.2K ﹤0.01% 2407

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Cutler Group's ESPR Position: Q2 2023 in Review

Cutler Group sold out of Esperion Therapeutics (ESPR) in Q2 2023, closing a stake of 1,500 shares — an estimated $2K sold.

Cutler Group first reported a position in ESPR in Q4 2015 and held it in 25 quarters. The position peaked at $543K in Q2 2017. 124 funds tracked by Wall St. Rank hold ESPR as of Q2 2023.

  • Cutler Group reported no remaining Esperion Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 Esperion Therapeutics shares in Q2 2023, an estimated $2K.
  • Cutler Group first reported a position in Esperion Therapeutics in Q4 2015 and held it in 25 quarters.
  • Cutler Group's Esperion Therapeutics position peaked at $543K in Q2 2017.
  • 124 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.